Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMA
US7807815B2 · kind B2 · utility
58Cited by
29References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 30, 2005 |
| Grant date | Oct 5, 2010 |
| Priority date | — |
| Expiry date | Mar 20, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides siRNA molecules and methods of using such siRNA molecules to modulate an immune response and to silence expression of a target gene.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.